Subscribe to Updates
Get the latest creative news from FooBar about art, design and business.
- Retro Fitness, NFFF Partner for 9/11 Memorial Stair Climbs
- Study ranks Alabama among worst states for children’s nutrition
- Measuring Beyond the Machine
- Peta Murgatroyd Placed Family’s Well
- ‘Biased’ Channel 4 programme on ADHD misrepresented my views, says expert
- Why rapid weight loss can make you look older
- As a doctor, I’m fighting in Congress to lower health costs
- New Orleans women focus on health and connection at ‘Shake Back’ fit camp
Browsing: Weight Loss
Six weeks after STAT News reported Lilly’s retatrutide compassionate use of a single unnamed 79-year-old man through the FDA’s expanded access pathway, the Indianapolis drugmaker on Monday confirmed it has built a formal program — and set four eligibility criteria that most Americans with obesity will not be able to satisfy. The announcement, which came…
Researchers developing a new weight loss drug are looking for people to take part in clinical trials in Bradford
Never miss an important update on your stock portfolio and cut through the noise. Over 7 million investors trust Simply Wall St to stay informed where it matters for FREE
A few years ago, I interviewed a Black teen as part of a study on the health of Gen Z. What this ninth-grader from an inner-city community was most passionate about surprised me
Azitra, a biopharmaceutical company, is developing a clinically backed anti-aging ingredient with potential applications for post GLP-1 skin laxity. The ingredient, ATR-COSF, utilizes a novel supernatant formulation that contains an active recombinant human domain of the protein filaggrin (rHDfilaggrin) for cosmetic and skin care applications
Marta Rodríguez PeleteirotwitterDavid Nelsontwitter Update: Aug 3rd, 2026 06:01 EDT Sharefacebook twitter whatsapp Make us preferred on Google
When the FDA approved the Wegovy pill, the first oral semaglutide for weight management, in late December 2025 (with the launch following in early January 2026), the response was immediate. Patients who had spent months dreading their weekly injections suddenly had a new question for their doctors, and doctors suddenly had a much harder question…
Mounjaro, which has been leading the global boom in obesity treatments, improves fatty liver but does not sufficiently reverse inflammation and fibrosis in fat tissue, according to a new study
As interest in streamlined weight-management support grows in 2026, this AlkaBurn review examines the brand-stated five-ingredient formula, confirmed 138 mg caffeine dose, once-daily capsule format, current pricing, and the key questions diet-weary buyers should review before ordering
Walmart, Costco, and Amazon are moving to capture a growing share of the weight loss drug market as employers cut coverage and push patients toward direct-to-consumer prescription programs Retail chains view GLP-1 prescriptions as a way to pull in long-term customers, calculating that a patient who picks up a weight loss drug will return for…

